Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

A Boston-area cancer research lab will lay off more than 100 employees later this year, according to a new filing with the state. Mural Oncology in Waltham will lay off 117 people between June 14 and ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles.

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...

The study, published in the Journal of Clinical Investigation, reveals that pyrvinium pamoate—a drug approved in the 1950s to ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

MONDAY, April 21, 2025 (HealthDay News) — Immunotherapy might help keep lung cancer at bay for months or even years after the ...

Crown BioScience experts explore how 3D in vitro assays mimic the suppressive tumor microenvironment to improve drug response ...